Long-term contribution of human bone marrow mesenchymal stromal cells to skeletal muscle regeneration in mice

Cell Transplantation

Volumn 20, Issue 2, 2011, Pages 217-231

  de la Garza Rodea, Anabel S ^a   van der Velde, Ietje ^a   Boersma, Hester ^a   Gonçalves, Manuel A F V ^a   van Bekkum, Dirk W ^a   de Vries, Antoine A F ^a   Knaän Shanzer, Shoshan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone marrow; Cell therapy; Duchenne muscular dystrophy; Human mesenchymal stromal cell; NOD SCID mouse; Skeletal muscle regeneration

Indexed keywords

BETA GALACTOSIDASE; CARDIOTOXIN; SPECTRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MARROW MESENCHYMAL STROMAL CELL TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CELL COUNT; CELL FATE; CELL MIGRATION; CELL NUCLEUS; CHEMOLUMINESCENCE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYBRID MYOFIBER; IMPLANTATION; INJECTION; INJECTION SITE; MALE; MESENCHYME CELL; MOUSE; MUSCLE CELL; MUSCLE INJURY; MUSCLE REGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SKELETAL MUSCLE; TIBIALIS ANTERIOR MUSCLE; TIBIALIS ANTERIOR MUSCLE INJURY;

ADULT; ANIMALS; BETA-GALACTOSIDASE; BONE MARROW CELLS; CELL PROLIFERATION; CELLS, CULTURED; DIFFUSION; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; REGENERATION; STROMAL CELLS; TIME FACTORS;

MUS;

EID: 79955437543     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X522117     Document Type: Article

References (66)

1. Andersen, D. C.; Schroder, H. D.; Jensen, C. H. Noncultured adipose-derived. Exp. Cell Res. 314:2951-2964; 2008.
2. Benchaouir, R.; Meregalli, M.; Farini, A.; D'Antona, G.; Belicchi, M.; Goyenvalle, A.; Battistelli, M.; Bresolin, N.; Bottinelli, R.; Garcia, L.; Torrente, Y. Restoration of human dystrophin following transplantation of exon-skip-ping-engineered DMD patient stem cells into dystrophic mice. Cell Stem Cell 1:646-657; 2007.
3. Bianco, P.; Riminucci, M.; Gronthos, S.; Robey, P. G. Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 19:180-192; 2001.
4. Blaveri, K.; Heslop, L.; Yu, D. S.; Rosenblatt, J. D.; Gross, J. G.; Partridge, T. A.; Morgan, J. E. Patterns of repair of dystrophic mouse muscle: studies on isolated fibers. Dev. Dyn. 216:244-256; 1999.
5. Briguet, A.; Courdier-Fruh, I.; Foster, M.; Meier, T.; Magyar, J. P. Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse. Neuromuscul. Disord. 14:675-682; 2004.
6. Cossu, G.; Biressi, S. Satellite cells, myoblasts and other occasional myogenic progenitors: Possible origin, phenotypic features and role in muscle regeneration. Semin. Cell Dev. Biol. 16:623-631; 2005.
7. Couteaux, R.; Mira, J. C.; d'Albis, A. Regeneration of muscles after cardiotoxin injury. I. Cytological aspects. Biol. Cell 62:171-182; 1988.
8. Damme, A.; Thorrez, L.; Ma, L.; Vandenburgh, H.; Eyckmans, J.; Dell'Accio, F.; De Bari, C.; Luyten, F.; Lillicrap, D.; Collen, D.; Vanden-Driessche, T.; Chuah, M. K. Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal cells. Stem Cells 24: 896-907; 2006.
9. Da Silva Meirelles, L.; Caplan, A. I.; Nardi, N. B. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26:2287-2299; 2008.
10. Deans, R. J.; Moseley, A. B. Mesenchymal stem cells: Biology and potential clinical uses. Exp. Hematol. 28: 875-884; 2000.
11. De Bari, C.; Dell'Accio, F.; Tylzanowski, P.; Luyten, F. P. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 44:1928-1942; 2001.
12. De Bari, C.; Dell'Accio, F.; Vandenabeele, F.; Vermeesch, J. R.; Raymackers, J. M.; Luyten, F. P. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J. Cell Biol. 160:909-918; 2003.
13. Dellavalle, A.; Sampaolesi, M.; Tonlorenzi, R.; Tagliafico, E.; Sacchetti, B.; Perani, L.; Innocenzi, A.; Galvez, B. G.; Messina, G.; Morosetti, R.; Li, S.; Belicchi, M.; Peretti, G.; Chamberlain, J. S.; Wright, J. E.; Torrente, Y.; Ferrari, S.; Bianco, P.; Cossu, G. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat. Cell Biol. 9:255-267; 2007.
14. Dezawa, M.; Ishikawa, H.; Itokazu, Y.; Yoshihara, T.; Hoshino, M.; Takeda, S.; Ide, C.; Nabeshima, Y. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309:314-317; 2005.
15. Di Rocco, G.; Iachininoto, M. G.; Tritarelli, A.; Straino, S.; Zacheo, A.; Germani, A.; Crea, F.; Capogrossi, M. C. Myogenic potential of adipose-tissue-derived cells. J. Cell Sci. 119:2945-2952; 2006.
16. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Corten-bach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D.; Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317; 2006.
17. Eliopoulos, N.; Al-Khaldi, A.; Crosato, M.; Lachapelle, K.; Galipeau, J. A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice. Gene Ther. 10: 478-489; 2003.
18. Eliopoulos, N.; Stagg, J.; Lejeune, L.; Pommey, S.; Galipeau, J. Allogeneic marrow stromal cells are immune rejected by MHC class I-and class II-mismatched recipient mice. Blood 106:4057-4065; 2005.
19. Eppens, E. F.; van Mil, S. W.; de Vree, J. M.; Mok, K. S.; Juijn, J. A.; Oude-Elferink, R. P.; Berger, R.; Houwen, R. H.; Klomp, L. W. FIC1, the protein affected in two forms of hereditary cholestasis, is localized in the cholangiocyte and the canalicular membrane of the hepatocyte. J. Hepatol. 35:436-443; 2001.
20. Erices, A.; Conget, P.; Minguell, J. J. Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol. 109:235-242; 2000.
21. Ferrari, G.; Mavilio, F. Myogenic stem cells from the bone marrow: A therapeutic alternative for muscular dystrophy? Neuromuscul. Disord. 12:7-10; 2002.
22. Friedenstein, A. J.; Petrakova, K. V.; Kurolesova, A. I.; Frolova, G. P. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6:230-247; 1968.
23. Goncalves, M. A.; de Vries, A. A.; Holkers, M.; van de Watering, M. J.; der Velde-van Dijke, I.; van Nierop, G. P.; Valerio, D.; Knaan-Shanzer, S. Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion. Hum. Mol. Genet. 15:213-221; 2006.
24. Goncalves, M. A.; Pau, M. G.; de Vries, A. A.; Valerio, D. Generation of a high-capacity hybrid vector: packaging of recombinant adenoassociated virus replicative intermediates in adenovirus capsids overcomes the limited cloning capacity of adenoassociated virus vectors. Virology 288:236-246; 2001.
25. Goncalves, M. A.; Swildens, J.; Holkers, M.; Narain, A.; van Nierop, G. P.; van de Watering, M. J.; Knaan-Shanzer, S.; de Vries, A. A. Genetic complementation of human muscle cells via directed stem cell fusion. Mol. Ther. 16:741-748; 2008.
26. Goudenege, S.; Pisani, D. F.; Wdziekonski, B.; Di Santo, J. P.; Bagnis, C.; Dani, C.; Dechesne, C. A. Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD. Mol. Ther. 17:1064-1072; 2009.
27. Gronthos, S.; Mankani, M.; Brahim, J.; Robey, P. G.; Shi, S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc. Natl. Acad. Sci. USA 97:13625-13630; 2000.
28. Huang, H. I.; Chen, S. K.; Ling, Q. D.; Chien, C. C.; Liu, H. T.; Chan, S. H. Multilineage differentiation potential of fibroblast-like stromal cells derived from human skin. Tissue Eng. Part A. 16(5):1491-1501; 2010.
29. Ikemoto, M.; Fukada, S.; Uezumi, A.; Masuda, S.; Miyoshi, H.; Yamamoto, H.; Wada, H. R.; Masubuchi, N.; Miyagoe-Suzuki, Y.; Takeda, S. Autologous transplantation of SM/C-2.6(+) satellite cells transduced with microdystrophin CS1 cDNA by lentiviral vector into mdx mice. Mol. Ther. 15:2178-2185; 2007.
30. In't Anker, P. S.; Noort, W. A.; Scherjon, S. A.; Kleij-burg-van der Keur, C.; Kruisselbrink, A. B.; van Bezooijen, R. L.; Beekhuizen, W.; Willemze, R.; Kanhai, H. H.; Fibbe, W. E. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica 88: 845-852; 2003.
31. In't Anker, P. S.; Scherjon, S. A.; Kleijburg-van der Keur, C.; de Groot-Swings, G. M.; Claas, F. H.; Fibbe, W. E.; Kanhai, H. H. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22: 1338-1345; 2004.
32. In't Anker, P. S.; Scherjon, S. A.; Kleijburg-van der Keur, C.; Noort, W. A.; Claas, F. H.; Willemze, R.; Fibbe, W. E.; Kanhai, H. H. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102:1548-1549; 2003.
33. Karpati, G.; Molnar, M. J. Muscle fibre regeneration in human skeletal muscle diseases. In: Schiaffino, S.; Partridge, T., eds. Skeletal muscle repair and regeneration, advances in muscle research 3. The Netherlands: Springer; 2008:199-215.
34. Karpati, G.; Pouliot, Y.; Zubrzycka-Gaarn, E.; Carpenter, S.; Ray, P. N.; Worton, R. G.; Holland, P. Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am. J. Pathol. 135:27-32; 1989.
35. Kinoshita, I.; Vilquin, J. T.; Asselin, I.; Chamberlain, J.; Tremblay, J. P. Transplantation of myoblasts from a transgenic mouse overexpressing dystrophin produced only a relatively small increase of dystrophin-positive membrane. Muscle Nerve 21:91-103; 1998.
36. Knaan-Shanzer, S.; van de Watering, M. J.; der Velde-van Dijke, I.; Goncalves, M. A.; Valerio, D.; de Vries, A. A. Endowing human adenovirus serotype 5 vectors with fiber domains of species B greatly enhances gene transfer into human mesenchymal stem cells. Stem Cells 23:1598-1607; 2005.
37. Knaan-Shanzer, S.; van der Velde-van Dijke, I.; van de Watering, M. J.; de Leeuw, P. J.; Valerio, D.; van Bekkum, D. W.; de Vries, A. A. Phenotypic and functional reversal within the early human hematopoietic compartment. Stem Cells 26:3210-3217; 2008.
38. Kuznetsov, S. A.; Mankani, M. H.; Gronthos, S.; Sato-mura, K.; Bianco, P.; Robey, P. G. Circulating skeletal stem cells. J. Cell Biol. 153:1133-1140; 2001.
39. Le Blanc, K.; Frassoni, F.; Ball, L.; Locatelli, F.; Roelofs, H.; Lewis, I.; Lanino, E.; Sundberg, B.; Bernardo, M. E.; Remberger, M.; Dini, G.; Egeler, R. M.; Bacigalupo, A.; Fibbe, W.; Ringden, O. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371:1553-1554; 2008.
40. Lee, J. H.; Kosinski, P. A.; Kemp, D. M. Contribution of human bone marrow stem cells to individual skeletal myotubes followed by myogenic gene activation. Exp. Cell Res. 307:174-182; 2005.
41. Liu, Y.; Yan, X.; Sun, Z.; Chen, B.; Han, Q.; Li, J.; Zhao, R. C. Flk-1+ adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice. Stem Cells Dev. 16:695-706; 2007.
42. Luth, E. S.; Jun, S. J.; Wessen, M. K.; Liadaki, K.; Gussoni, E.; Kunkel, L. M. Bone marrow side population cells are enriched for progenitors capable of myogenic differentiation. J. Cell Sci. 121:1426-1434; 2008.
43. Mueller, G. M.; O'Day, T.; Watchko, J. F.; Ontell, M. Effect of injecting primary myoblasts versus putative muscle-derived stem cells on mass and force generation in mdx mice. Hum. Gene Ther. 13:1081-1090; 2002.
44. Otto, A.; Collins-Hooper, H.; Patel, K. The origin, molecular regulation and therapeutic potential of myogenic stem cell populations. J. Anat. 215:477-497; 2009.
45. Partridge, T. Myoblast transplantation. Neuromuscul. Disord. 12:3-6; 2002.
46. Patel, A. N.; Park, E.; Kuzman, M.; Benetti, F.; Silva, F. J.; Allickson, J. G. Multipotent menstrual blood stromal stem cells: Isolation, characterization, and differentiation. Cell Transplant. 17:303-311; 2008.
47. Peault, B.; Rudnicki, M.; Torrente, Y.; Cossu, G.; Tremblay, J. P.; Partridge, T.; Gussoni, E.; Kunkel, L. M.; Huard, J. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol. Ther. 15:867-877; 2007.
48. Pittenger, M. F.; Mackay, A. M.; Beck, S. C.; Jaiswal, R. K.; Douglas, R.; Mosca, J. D.; Moorman, M. A.; Simo-netti, D. W.; Craig, S.; Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147; 1999.
49. Quenneville, S. P.; Chapdelaine, P.; Skuk, D.; Paradis, M.; Goulet, M.; Rousseau, J.; Xiao, X.; Garcia, L.; Tremblay, J. P. Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models. Mol. Ther. 5:431-438; 2007.
50. Rodriguez, A. M.; Pisani, D.; Dechesne, C. A.; Turc-Carel, C.; Kurzenne, J. Y.; Wdziekonski, B.; Villageois, A.; Bagnis, C.; Breittmayer, J. P.; Groux, H.; Ailhaud, G.; Dani, C. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J. Exp. Med. 201: 1397-1405; 2005.
51. Sacco, A.; Doyonnas, R.; LaBarge, M. A.; Hammer, M. M.; Kraft, P.; Blau, H. M. IGF-1 increases bone marrow contribution to adult skeletal muscle and enhances the fusion of myelomonocytic precursors. J. Cell Biol. 171:483-492; 2005.
52. Sampaolesi, M.; Blot, S.; D'Antona, G.; Granger, N.; Tonlorenzi, R.; Innocenzi, A.; Mognol, P.; Thibaud, J. L.; Galvez, B. G.; Barthelemy, I.; Perani, L.; Mantero, S.; Guttinger, M.; Pansarasa, O.; Rinaldi, C.; Cusella De Angelis, M. G.; Torrente, Y.; Bordignon, C.; Bottinelli, R.; Cossu, G. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444:574-579; 2006.
53. Schmalbruch, H. The morphology of regeneration of skeletal muscles in the rat. Tissue Cell 8:673-692; 1976.
54. Shi, D.; Reinecke, H.; Murry, C. E.; Torok-Storb, B. Myo-genic fusion of human bone marrow stromal cells, but not hematopoietic cells. Blood 104:290-294; 2004.
55. Skuk, D.; Goulet, M.; Roy, B.; Piette, V.; Cote, C. H.; Chapdelaine, P.; Hogrel, J. Y.; Paradis, M.; Bouchard, J. P.; Sylvain, M.; Lachance, J. G.; Tremblay, J. P. First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: Eighteen months follow-up. Neuromuscul. Disord. 17:38-46; 2007.
56. Smythe, G. M.; Hodgetts, S. I.; Grounds, M. D. Immunobiology and the future of myoblast transfer therapy. Mol. Ther. 1:304-313; 2000.
57. Stephan, L.; Bouchentouf, M.; Mills, P.; Lafreniere, J. F.; Tremblay, J. P. 1,25-Dihydroxyvitamin D3 increases the transplantation success of human muscle precursor cells in SCID mice. Cell Transplant. 16:391-402; 2007.
58. + stem cells in Duchenne muscle patients. Cell Transplant. 16:563-577; 2007.
59. Torrente, Y.; Belicchi, M.; Sampaolesi, M.; Pisati, F.; Meregalli, M.; D'Antona, G.; Tonlorenzi, R.; Porretti, L.; Gavina, M.; Mamchaoui, K.; Pellegrino, M. A.; Furling, D.; Mouly, V.; Butler-Browne, G. S.; Bottinelli, R.; Cossu, G.; Bresolin, N. Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J. Clin. Invest. 114: 182-195; 2004.
60. Urish, K.; Kanda, Y.; Huard, J. Initial failure in myoblast transplantation therapy has led the way toward the isolation of muscle stem cells: Potential for tissue regeneration. Curr. Top. Dev. Biol. 68:263-280; 2005.
61. van Tuyn, J.; Knaan-Shanzer, S.; van de Watering, M. J.; de Graaf, M.; van der Laarse, A.; Schalij, M. J.; van der Wall, E. E.; de Vries, A. A.; Atsma, D. E. Activation of cardiac and smooth muscle-specific genes in primary human cells after forced expression of human myocardin. Cardiovasc. Res. 67:245-255; 2005.
62. van Tuyn, J.; Pijnappels, D. A.; de Vries, A. A.; de Vries, I.; van der Velde-van Dijke, I.; Knaan-Shanzer, S.; van der Laarse, A.; Schalij, M. J.; Atsma, D. E. Fibroblasts from human postmyocardial infarction scars acquire properties of cardiomyocytes after transduction with a recombinant myocardin gene. FASEB J. 21:3369-3379; 2008.
63. Vieira, N. M.; Bueno, C. R.; Brandalise, Jr., V.; Morales, L. V.; Zucconi, E.; Secco, E.; Suzuki, M. F.; Camargo, M. M.; Bartolini, P.; Brum, P. C.; Vainzof, M.; Zatz, M. SJL dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosuppression. Stem Cells 26:2391-2398; 2008.
64. Williams, J. T.; Southerland, S. S.; Souza, J.; Calcutt, A. F.; Cartledge, R. G. Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am. Surg. 65:22-26; 1999.
65. Zheng, C.; Yang, S.; Guo, Z.; Liao, W.; Zhang, L.; Yang, R.; Han, Z. C. Human multipotent mesenchymal stromal cells from fetal lung expressing pluripotent markers and differentiating into cell types of three germ layers. Cell Transplant. 18:1093-1109; 2009.
66. Zuk, P. A.; Zhu, M.; Mizuno, H.; Huang, J.; Futrell, J. W.; Katz, A. J.; Benhaim, P.; Lorenz, H. P.; Hedrick, M. H. Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 7:211-228; 2001.